Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Heidenreich

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Haematologica|July 2, 2026
Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineageBexultan Kazybay, Mauricio N Ferrao Blanco, Olaf Heidenreich, et al.
Quantitative Imaging in Medicine and Surgery|July 9, 2013
Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3TRichard Keith Downs, Mariah Haider Bashir, Chin Kau Ng, et al.
The Journal of Cell Biology|February 13, 2002
Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cellsGerhard Schratt, Ulrike Philippar, Jürgen Berger, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETODani Osman, Vanessa Gobert, Frida Ponthan, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Pediatric Blood & Cancer|March 11, 2015
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemiaJudith Weiland, Alex Elder, Victoria Forster, et al.
Current Protocols in Molecular Biology|July 2, 2015
Gene Silencing by RNAi in Mammalian CellsFrida Ponthan, Narazah Mohd Yusoff, Natalia Martinez Soria, et al.
Leukemia|August 16, 2025
Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironmentMauricio N Ferrao Blanco, Bexultan Kazybay, Mirjam Belderbos, et al.
Blood|July 28, 2005
Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cellsMaria Thomas, Andreas Gessner, Hans-Peter Vornlocher, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Haematologica|July 2, 2026
Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineageBexultan Kazybay, Mauricio N Ferrao Blanco, Olaf Heidenreich, et al.
Quantitative Imaging in Medicine and Surgery|July 9, 2013
Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3TRichard Keith Downs, Mariah Haider Bashir, Chin Kau Ng, et al.
The Journal of Cell Biology|February 13, 2002
Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cellsGerhard Schratt, Ulrike Philippar, Jürgen Berger, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETODani Osman, Vanessa Gobert, Frida Ponthan, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Pediatric Blood & Cancer|March 11, 2015
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemiaJudith Weiland, Alex Elder, Victoria Forster, et al.
Current Protocols in Molecular Biology|July 2, 2015
Gene Silencing by RNAi in Mammalian CellsFrida Ponthan, Narazah Mohd Yusoff, Natalia Martinez Soria, et al.
Leukemia|August 16, 2025
Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironmentMauricio N Ferrao Blanco, Bexultan Kazybay, Mirjam Belderbos, et al.
Blood|July 28, 2005
Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cellsMaria Thomas, Andreas Gessner, Hans-Peter Vornlocher, et al.
Pageof 10